Related Experiment Video
Updated: May 29, 2026

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
Published on: October 29, 2015
Inhibition of enterovirus 71 replication by chrysosplenetin and penduletin
Qin-Chang Zhu1, Yi Wang, Ya-Ping Liu
1State Key Laboratory of Respiratory Diseases, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China.
Insights
Chrysosplenetin and penduletin show potent antiviral activity against enterovirus 71 (EV71) by inhibiting viral RNA replication. These natural compounds offer a promising avenue for developing new treatments for EV71 infections in children.
Area of Science:
- Natural Product Chemistry
- Virology
- Drug Discovery
Background:
- Enterovirus 71 (EV71) infections pose a significant threat to young children, causing severe neurological disease and mortality.
- Current therapeutic options for EV71 are limited, highlighting the urgent need for novel antiviral agents.
Purpose of the Study:
- To investigate the anti-EV71 activity of chrysosplenetin and penduletin, two o-methylated flavonols from Laggera pterodonta.
- To evaluate the efficacy and preliminary mechanism of action of these compounds against EV71.
Main Methods:
- In vitro antiviral activity assessed using cytopathic effect (CPE) inhibition assays, including plaque reduction and virus yield inhibition.
- Cytotoxicity evaluated in African green monkey kidney (Vero) and human rhabdomyosarcoma (RD) cells to determine selectivity indices (SI).
- Mechanism of action explored through time-of-addition assays and assessment of viral RNA replication inhibition.
Main Results:
- Chrysosplenetin and penduletin demonstrated strong in vitro activity against EV71 with low cytotoxicity, exhibiting 50% inhibitory concentration (IC50) values around 0.20 μM.
- High selectivity indices (SI) were observed in both Vero (107.5–655.6) and RD (69.5–200.5) cells.
- Compounds were found to inhibit viral RNA replication, not virus entry or direct inactivation, with optimal efficacy when administered within 4 hours post-infection.
- Activity was also observed against other human enteroviruses.
Conclusions:
- Chrysosplenetin and penduletin are effective inhibitors of EV71 replication, acting by suppressing viral RNA synthesis.
- These flavonols exhibit favorable safety profiles and broad-spectrum activity against enteroviruses.
- The findings present chrysosplenetin and penduletin as promising candidates for the development of novel anti-EV71 therapeutics.
Abstract:
In recent years, enterovirus 71 (EV71) infections have caused an increasing epidemic in young children, accompanying with more severe nervous system disease and more deaths. Unfortunately, there is no specific medication for it so far. Here we investigated the anti-EV71 activity of chrysosplenetin and penduletin, two o-methylated flavonols isolated from the leaves of Laggera pterodonta. These two compounds were found to have strong activity in vitro against EV71 with low cytotoxicity. In the cytopathic effect (CPE) inhibition assays, both plaque reduction assay and virus yield inhibition assay, the compounds showed a similar 50% inhibitory concentration (IC(50)) value of about 0.20 μM. The selectivity indices (SI) of chrysosplenetin and penduletin were 107.5 and 655.6 in African green monkey kidney (Vero) cells, and 69.5 and 200.5 in human rhabdomyosarcoma (RD) cells, accordingly. The preliminary mechanism analysis indicates that they function not through blocking virus entry or inactivating virus directly but inhibiting viral RNA replication. In the time-of-addition assay, both compounds inhibited progeny virus production and RNA replication by nearly 100% when introduced within 4h post infection. In addition to EV71, both compounds inhibited several other human enteroviruses with similar efficacy. These findings provide a significant lead for the discovery of anti-EV71 drug.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release
Respiratory Syncytial Virus Disease
Antiviral Nucleoside Inhibitors
Inhibitors of Virion Maturation and Assembly

